“MULTIMODALITY TREATMENT OF GLIOBLASTOMA PATIENTS USING DIFFERENT TEMOZOLOMIDE REGIMENS IN POSTOPERATIVE CHEMORADIOTHERAPY” (2017) Voprosy onkologii, 63(6), pp. 915–919. doi:10.37469/0507-3758-2017-63-6-915-919.